1,5-Bis(3,4-dimethoxyphenyl)-3-pentanol | 68081-13-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1,5-Bis(3,4-dimethoxyphenyl)-3-pentanol
• 英文别名: GO-Y042；3-hydroxy-1.5-bis-(3.4-dimethoxy-phenyl)-pentane；3-Hydroxy-1.5-bis-(3.4-dimethoxy-phenyl)-pentan；1,5-Bis(3,4-dimethoxyphenyl)pentan-3-ol
• CAS: 68081-13-0
• 化学式: C₂₁H₂₈O₅
• 分子量: 360.45
• InChiKey: WVXYUIOLIYNQAB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  26
• 可旋转键数：
  10
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  57.2
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  1,5-Bis(3,4-dimethoxyphenyl)-3-pentanol 在 四氯化锡 作用下， 生成 4,5,12,13-Tetramethoxytetracyclo[7.6.2.02,7.010,15]heptadeca-2,4,6,10,12,14-hexaene
  参考文献：
  名称：

  Anodic oxidation of 1,2,3,4-tetrahydronaphthalene and isochroman analogs of 1-benzyl and 1-phenethyl isoquinoline alkaloids. Products and mechanism of the intramolecular cyclization

  摘要：

  DOI：

  10.1021/jo01316a008
• 作为产物：
  描述：

  1,5-bis(3,4-dimethoxyphenyl)pentan-3-one 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 为溶剂， 以76%的产率得到1,5-Bis(3,4-dimethoxyphenyl)-3-pentanol
  参考文献：
  名称：

  Structure–activity relationship of C5-curcuminoids and synthesis of their molecular probes thereof

  摘要：

  A series of novel analogues of 1,5-bis(4-hydroxy-3-methoxyphenyl)-penta-(1E,4E)-1,4-dien-3-one (C-5-curcumin), which is a natural analogue of curcumin isolated from the rhizomes of Curcuma domestica Val. (Zingiberacea), were synthesized and evaluated for their cytotoxicities against human colon cancer cell line HCT-116 to conclude the SAR of C-5-curcuminoids for further development of their use in cancer chemotherapy: (1) Bis(arylmethylidene) acetone serves as a promising skeleton for eliciting cytotoxicity. (2) The 3-oxo-1,4-pentadiene structure is essential for eliciting cytotoxicity. (3) As for the extent of the aromatic substituents, hexasubstituted compounds exhibit strong activities, in which 3,4,5-hexasubstitution results in the highest potency. (5) The symmetry between two aryl rings is not an essential requirement for bis(arylmethylidene) acetones to elicit cytotoxicity. (6) para-Positions allows the installation of additional functional groups for use as molecular probes. By taking advantage of the SAR diagram, we have elaborated several advanced derivatives having GI(50) of single-digit micromolar potencies that will function as molecular probes to target and/or report key biomolecules interacting with curcumin and C-5-curcumin. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2009.12.045

文献信息

• Curcumin analogs with anti-tumor and anti-angiogenic properties
  申请人：——

  公开号：US20020019382A1

  公开（公告）日：2002-02-14

  The present invention is directed to curcumin analogs exhibiting anti-tumor and anti-angiogenic properties, pharmaceutical formulations including such compounds and methods of using such compounds.

  本发明涉及表现出抗肿瘤和抗血管生成特性的姜黄素类似物，包括这些化合物的药物配方以及使用这些化合物的方法。
• Antimicrobial Activity of Monoketone Curcuminoids Against Cariogenic Bacteria
  作者：Tatiana M. Vieira、Isabella A. dos Santos、Thayná S. Silva、Carlos H. G. Martins、Antônio E. M. Crotti

  DOI：10.1002/cbdv.201800216

  日期：2018.8

  We evaluated the antimicrobial activity of 25 monoketone curcuminoids (MKCs) against a representative panel of cariogenic bacteria in terms of their minimum inhibitory concentration (MIC) values. Curcumin A (10) displayed promising activity against Streptococcus mutans (MIC = 50 μg/ml) and Streptococcus mitis (MIC = 50 μg/ml) as well as moderate activity against S. sanguinis (MIC = 100 μg/ml), Lactobacillus

  我们根据最低抑菌浓度 (MIC) 值评估了 25 种单酮类姜黄素 (MKC) 对一组有代表性的致龋菌的抗菌活性。姜黄素 A (10) 对变形链球菌 (MIC = 50 μg/ml) 和缓和链球菌 (MIC = 50 μg/ml) 显示出有前景的活性，以及​​对血链球菌 (MIC = 100 μg/ml)、干酪乳杆菌的中等活性(MIC = 100 μg/ml) 和唾液链球菌 (MIC = 200 μg/ml)。结果表明化合物 10 的活性高于其双β-二酮类似物。此外，化合物 3a（1,5-双（4-甲基苯基）戊烷-3-one）和 7b（1,5-双（4-溴苯基）戊烷-3-醇）对 S. mitis 具有中等活性（MIC = 100 μg/ml）和唾液链球菌（MIC = 200 μg/ml）。
• [EN] CURCUMIN ANALOGUES FOR TREATING CANCER<br/>[FR] ANALOGUES DE CIRCUMINE DESTINES AU TRAITEMENT DU CANCER
  申请人：UNIV EMORY

  公开号：WO2001040188A1

  公开（公告）日：2001-06-07

  The present invention is directed to curcumin analogs (I), wherein Y is OH, halogen, or CF3; Z is H, OH, OR1, halogen, or CF3; X1 and X2 are independently C or N; and A is as defined in the application; exhibiting anti-tumor and anti-angiogenic properties, pharmaceutical formulations including such compounds and methods of using such compounds.

  本发明涉及姜黄素类似物(I)，其中Y为OH、卤素或CF3；Z为H、OH、OR1、卤素或CF3；X1和X2独立地为C或N；A如本申请所定义；该类似物具有抗肿瘤和抗血管生成作用，制备包括这些化合物的制药组合物以及使用这些化合物的方法。
• CURCUMIN ANALOGS WITH ANTI-TUMOR AND ANTI-ANGIOGENIC PROPERTIES
  申请人：Snyder James P.

  公开号：US20080234320A1

  公开（公告）日：2008-09-25

  The present invention is directed to curcumin analogs exhibiting anti-tumor and anti-angiogenic properties, pharmaceutical formulations including such compounds and methods of using such compounds.

  本发明涉及展现抗肿瘤和抗血管生成特性的姜黄素类似物，包括这些化合物的制药配方和使用这些化合物的方法。
• CURCUMIN ANALOGUES FOR TREATING CANCER
  申请人：Emory University

  公开号：EP1242379A1

  公开（公告）日：2002-09-25